Faculty of 1000 to launch open access publishing venture

Friday, February 17, 2012 01:50 PM

Faculty of 1000 (F1000) is set to launch F1000 Research, a new fully open access publishing program across biology and medicine, later this year.

The program will address the major issues afflicting scientific publishing today: timely dissemination of research, peer review and sharing of data. Diverging from traditional journal publishing, F1000 Research will offer immediate publication; open, post-publication peer review; open revisioning of work including ongoing updates; and encouragement of raw data deposition and publication.

In addition, F1000 Research will accept a broad range of article formats and will encourage content types now routinely rejected, such as negative results, case studies, thought experiments, preliminary analyses and incomplete data sets.

“The open access model has addressed effectively the issue of inadequate access to research findings,” Vitek Tracz, chairman and founder of F1000. “It did not address the major issues around communicating the research finding: the delays in access, the inadequacies of peer review and the complexities of data publishing. It is up to collaboration between researchers and publishers to come up with a solution, and we are determined to be a part of it.”

Dr. Rebecca Lawrence, who is leading the project at F1000, added, “Many questions remain as we fine tune F1000 Research to break new ground in scholarly publishing. We therefore invite those working in the bioresearch community, institutions, funders, data centers and repositories, and data mining and informatics groups to join us in open discussion and debate about these many outstanding issues—via the RSS feed or by Twitter: @F1000Research.”

F1000 was conceived in 2002 as a collaboration of 1000 international faculty members. It identifies and evaluates the most important articles in biology and medical research publications.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs